Title : Six-month preoperative octreotide treatment in unselected, de novo patients with acromegaly: effect on biochemistry, tumour volume, and postoperative cure.

Pub. Date : 2011 Jun

PMID : 21521254






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 This prospective study investigates effect of 6-month treatment with octreotide long-acting repeatable (LAR) on insulin-like growth factor-1 (IGF-1) and growth hormone (GH) levels, pituitary function, tumour regression and postoperative cure in de novo acromegalic patients. Octreotide growth hormone 1 Homo sapiens
2 The GH reduction following an acute octreotide test was 81 +- 19% and associated with long-term GH reduction (r = 0 78, P < 0 0005). Octreotide growth hormone 1 Homo sapiens
3 The GH reduction following an acute octreotide test was 81 +- 19% and associated with long-term GH reduction (r = 0 78, P < 0 0005). Octreotide growth hormone 1 Homo sapiens